InflaRx N.V(NASDAQ:IFRX) 
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company...
Website: http://www.inflarx.de
Founded: 2018
Full Time Employees: 43
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.10
H 1.10
L 0.97
C 1.01
V 319,776
10EMA 1.01
20EMA 1.01
60EMA 1.01
120EMA 1.01
250EMA 1.01